The Organizing Committee of Spine Conference 2020 has the pleasure to invite you all to attend the International Conference on Spine and Spinal Disorders to be held in London, UK on the 12th and 13th of November 2020.
We are very proud to promote the dissemination of scientific knowledge and strengthening the friendship among the professionals working in the complex and challenging field of Spinal Disorders. After the resounding success of Spine 2019 and under the guidance of Spine Congress 2020’s scientific committee, we are looking forward to an outperforming scientific program.
The Spine Conference 2020 will emphasize on building top-notch keynote lectures, speaker sessions, workshops, and young researchers forum that flags high tech progresses at the global level. Subsequently, there will be symposia, case discussions and exhibitions demonstrating new theories and practise in spine and it’s subspecialties.
We are also glad to invite eminent professors, scientists, surgeons, residents, and fellows around the globe to propagate the most advanced idea and technologies in spine care.
London is the world’s leading international business centre and is central to the various universities, educational institutes and research facilities whose expertise business or academic can be strengthened.
We are passionately working to ensure this meeting be a grand success and a memorable to the participants. We look forward to seeing you all in Spine Conference 2020 and hopefully to enjoy the hospitality of the Great Britain.
At Pulsus Group, It is our ideology to bring maximum exposure to our attendees, so we make sure the event is a blend which covers professionals such as Spine Surgeons, Neurologists, Neurosurgeons, Scientists, Neurosurgery Researchers, Academic Scientists, and Diagnostic Laboratory Professionals from academia & Industry making the Spine Coference 2020 annual meeting a perfect platform.
The Spine Conference 2020 will be organized around theme “Spinal Disorders - Dissemination of Research Findings to Transform Your Practice and Improve Outcomes”. Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Spine Surgery, Spine Care and share the cross-cultural experiences of various treatment procedures and rehabilitation methods.
Spine Conference 2020 is an annual meeting of Spine Surgeons and Allied Health Professionals as well as committees to discuss the future of the Spine Disorders in terms of diagnosis, treatment, and transition care development.
With members from around the world focused on learning about Spine Surgery and its advances; this is your best opportunity to reach the largest assemblage of participants from the Spine Community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the neurosurgical treatment and diagnosis, and receive name recognition at this 2-day event. World-renowned Speakers, the most recent techniques, developments, and the newest updates in the field of Neurospine Surgery and its advanced treatments which includes Neuroplasticity, Computational Neuroscience, Neuro Physiotherapy, Key-hole Brain Surgery, Neuro-Endoscopy, Neuro-Oncology, Neurodegenerative Disorders, Neuronal Disorders, Robotic Neurosurgery are hallmarks of this Spine Conference.
Spinal implants are used to treat spinal deformities such as isthmic spondylolisthesis and spinal stenosis. Spinal stenosis is usually a common problem in men and women over 50 years of age. With the increasing age, structural changes occur to the spine which includes joint issues, slip disk, and increasing stiffness of the tissue supporting the spine. This leads to the development of spinal deformities or impairment.
Factors such as rising occurrence and prevalence of spinal ailments, development of safer technology and cost-effective spinal devices, and increasing demand for minimally invasive spine surgery are driving the growth of the spinal implants market. Conversely, factors such as high procedural costs, stringent regulatory guidelines for the approval of new medical devices, and lack of reimbursements in developing countries are hampering the growth of the global spinal implants market.
Global spine biologics market generated revenue of $1,644 million in 2015 and is projected to reach $2,214 million by 2022, growing at a CAGR of 4.3% during the forecast period. Spine biologics are used during spine fusion surgery for the treatment of spinal deformities such as trauma, tumors, degenerative disc disease, and spinal cord injuries. Increase in geriatric population, advantages of biologics such as minimal postoperative time, faster recovery, and their ability to activate cellular growth are the factors that drive the market growth. However, unfavorable reimbursement scenario, higher cost of the bone grafts, and certain ethical issues related to bone grafting procedures are expected to restrain the growth of the market.
Biologics are used during spinal fusion procedure, as they stimulate bone growth formation through the inflammatory stage, repair stage, and remodelling stage. Therefore, the rise in the number of spinal fusion surgery boosts the use of biologics.
Increase in geriatric population is the major factor anticipated to fuel the demand for biologics in the future. For instance, Spinal Disorders such as spinal stenosis is the most common problem in men and women over 50 years. Aging leads to structural alterations in spine such as thickening of the band of the tissue that supports the spine and enlargement of bones & joints, thus resulting in spinal impairment. According to “Eurostat”, the population of the European Union (EU) was estimated to be 508.5 million on January 1, 2018. Aged population (65 or over) had a share of 18.9%, which showed an increase of 0.4% compared to the previous year. Therefore, older people who are at a higher risk to develop spinal deformities have increased chances to undergo spinal fusion surgery, which in turn is projected to increase the demand for spine biologics.
Key Findings of the Spine Biologics Market: